Navigation Links
Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
Date:8/19/2007

Pharmatek Now Offers Contract Cytotoxic & High-Potent Analytical,

Formulation and Manufacturing Services

SAN DIEGO, Aug. 16 /PRNewswire/ -- Pharmatek Laboratories, Inc. today announced the addition of cytotoxic and high-potent drug development capabilities to its pharmaceutical chemistry development services. Cytotoxic and high-potent services include analytical method development, preformulation testing, formulation development, manufacturing for early phase clinical trials, release testing, and stability testing and storage.

"This expansion was driven by an increase in demand for cytotoxic and high-potent drug development and manufacturing outsourcing among our clients," said Dr. Jeffrey Bibbs, CEO of Pharmatek. "This added capability enables us to provide a broader level of services to our clients with cytotoxic and high-potent candidates."

Pharmatek's cytotoxic and high-potent development services will be carried out in a separate dedicated facility. Manufacturing capability includes two validated and licensed class 100,000 high-containment suites designed with barrier technology for cGMP manufacturing of final form drug products. Dedicated HVAC and HEPA filtration systems ensure product containment within the suites. Personnel are protected through strict gowning and control procedures to ensure employee safety while working in the suites.

"Pharmatek has been a valued resource for the development and manufacturing of non-potent drugs for more than eight years," said Timothy Scott, president of Pharmatek. "This investment positions Pharmatek to become a leading cytotoxic and high-potent drug development service provider."

About Pharmatek Laboratories, Inc.

Pharmatek Laboratories Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discov
'/>"/>

SOURCE Pharmatek Laboratories, Inc.

Copyright©2007 PR Newswire.

Page: 1 2

Related biology technology :

1. LIVE/DEAD Viability/Cytotoxicity Assay for Animal Cells Using the SpectraMax Gemini XS Fluorescence Microplate Reader (MaxLine Application Note #43)
2. The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis
3. Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins
4. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
5. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
6. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
7. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
8. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
9. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
10. Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System
11. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 /PRNewswire/ -   JOLT , a leading technology ... join its growing portfolio of startups. Next-level tech and ... JOLT accelerator, and Cohort four is no ... Since its launch in July 2012, JOLT ... of financing. Now at 23 investments, JOLT,s portfolio has ...
(Date:7/28/2014)... Wis. , July 28, 2014   Propeller ... respiratory disease, announced the hire of Brad Towle ... Towle will be responsible for driving the company,s sales ... broad experience in healthcare, and specifically his past role ... insight to the company at this pivotal time in ...
(Date:7/28/2014)... , July 28, 2014  InterMune, Inc. (NASDAQ: ... release its second quarter 2014 financial results at the ... 2014. A live conference call and webcast will be hosted ... day. Interested investors and others may participate ... +1 212-231-2900 (international), conference ID#21728775. A replay of the webcast ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 Canada ... key market data on the Canada Endoscopy Visualization ... of US dollars, volume (in units) and average ... High-End Endoscopy Visualization Systems, Mid-Range Endoscopy Visualization Systems ... Report at http://www.marketresearchreports.biz/analysis/213254 . , The report ...
Breaking Biology Technology:JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2InterMune to Release Second Quarter Financial Results on August 6 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5
... and for opening new food and beverage product categories ... 16 Frost & Sullivan, the international growth consulting ... 2008 North American Food and Beverage Probiotics Product Innovation ... strain, Ganeden BC30 (TM), for opening new development ...
... - The American Journal of Medicine , ... Medicine (AJM), one of Elsevier,s flagship health,sciences journals, has introduced ... forum where physicians and other,healthcare professionals can discuss the research ... Journal. , "The American ...
... Reduced Use of Chemicals Among Greatest Benefits , ... ... a few developing countries that have made significant progress in plant ... released, Dr. Elíbio Rech, a biotechnology researcher at Embrapa in Brazil, ...
Cached Biology Technology:Ganeden Biotech Receives Frost & Sullivan 'Probiotics Product Innovation' Award 2Ganeden Biotech Receives Frost & Sullivan 'Probiotics Product Innovation' Award 3Elsevier Introduces The American Journal of Medicine Blog 2Elsevier Introduces The American Journal of Medicine Blog 3New Online Video Features Brazilian Researcher Elbio Rech 2New Online Video Features Brazilian Researcher Elbio Rech 3
(Date:7/27/2014)... Microorganisms like bacteria and fungi can evade treatment by ... antifungal drugs. These permanent mutations were once thought to ... Now a new study has shown that microorganisms can ... as epimutations -- to gain the benefits of drug ... was discovered in a fungus called Mucor circinelloides, it ...
(Date:7/25/2014)... 25, 2014 In the first broad-scale estimate of air ... and collaborators calculated that trees are saving more than ... of acute respiratory symptoms. , While trees, pollution removal ... than 1 percent, the impacts of that improvement are ... reduced air pollution at nearly $7 billion every year ...
(Date:7/25/2014)... Boston, MA A study published online in the ... describes a novel approach to preventing cervical cancer based ... cervical cancer after removal of a discrete population of ... from a study that looked at squamocolumnar junction cells, ... canal and have been implicated as the origins of ...
Breaking Biology News(10 mins):Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3First national study finds trees saving lives, reducing respiratory problems 2Clearing cells to prevent cervical cancer 2
... at the UAB,s Institute of Environmental Science and Technology ... analysed the potential of different species of microalgae for ... the quantity of lipids per cell (essential for obtaining ... of marine algae that has received little attention till ...
... Human Frontier Science Program Organization (HFSPO) is awarding $34 ... competition for the HFSP Research Grants. Applicants went through ... that started with 715 submitted letters of intent. This ... scientists) together with 23 Program Grants (involving 81 scientists). ...
... associate a picture with a reward, the reward by ... monkeys, visual cortex. This finding was made by neurophysiologists ... Medical School) and American colleagues using functional brain scans ... Neuron . Our visual perception is not determined ...
Cached Biology News:Microalgae could be a profitable source of biodiesel 2Impressive list of research teams for the 2013 HFSP Research Grants 2Reward linked to image is enough to activate brain's visual cortex 2
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Tropomyosin 4 [Tm4]...
IHC Select Anti-p53, prediluted,wild & mutant, a.a. 19-26, clone DO-7 Immunogen: Human p53 Available Date: 37775...
Nestin, Human...
Biology Products: